James F. Oliviero III, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 25,000 shares at $15.69 ($392K) on 2014-12-10, disclosed to the SEC on 2014-12-12.
Open-market sale of $392k KERX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |